CA2425557A1 - Anticholinergic agents that can be used as medicaments and method for the production thereof - Google Patents
Anticholinergic agents that can be used as medicaments and method for the production thereof Download PDFInfo
- Publication number
- CA2425557A1 CA2425557A1 CA002425557A CA2425557A CA2425557A1 CA 2425557 A1 CA2425557 A1 CA 2425557A1 CA 002425557 A CA002425557 A CA 002425557A CA 2425557 A CA2425557 A CA 2425557A CA 2425557 A1 CA2425557 A1 CA 2425557A1
- Authority
- CA
- Canada
- Prior art keywords
- medicaments
- production
- anticholinergic agents
- preparing
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Abstract
The present invention relates to new anticholinergics of general formula 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10050994.0 | 2000-10-14 | ||
DE10050994A DE10050994A1 (en) | 2000-10-14 | 2000-10-14 | New diphenylalkanoic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease |
PCT/EP2001/011226 WO2002032899A1 (en) | 2000-10-14 | 2001-09-28 | Novel anticholinergic agents that can be used as medicaments and method for the production thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2425557A1 true CA2425557A1 (en) | 2003-04-11 |
CA2425557C CA2425557C (en) | 2007-11-13 |
Family
ID=7659808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002425557A Expired - Lifetime CA2425557C (en) | 2000-10-14 | 2001-09-28 | Anticholinergic agents that can be used as medicaments and method for the production thereof |
Country Status (38)
Country | Link |
---|---|
EP (2) | EP1325001B1 (en) |
JP (2) | JP4109106B2 (en) |
KR (1) | KR100830359B1 (en) |
CN (1) | CN1275962C (en) |
AR (1) | AR035589A1 (en) |
AT (1) | ATE259805T1 (en) |
AU (2) | AU2002213975B2 (en) |
BG (1) | BG66225B1 (en) |
BR (1) | BR0114635A (en) |
CA (1) | CA2425557C (en) |
DE (2) | DE10050994A1 (en) |
DK (1) | DK1325001T3 (en) |
EA (1) | EA005816B1 (en) |
EC (1) | ECSP034542A (en) |
EE (1) | EE05179B1 (en) |
ES (1) | ES2215147T3 (en) |
HK (1) | HK1060566A1 (en) |
HR (1) | HRP20030278B1 (en) |
HU (1) | HUP0301203A3 (en) |
IL (2) | IL155334A0 (en) |
ME (1) | MEP39908A (en) |
MX (1) | MXPA03003160A (en) |
MY (1) | MY127144A (en) |
NO (1) | NO328207B1 (en) |
NZ (1) | NZ525836A (en) |
PE (1) | PE20020433A1 (en) |
PL (1) | PL207311B1 (en) |
PT (1) | PT1325001E (en) |
RS (1) | RS50464B (en) |
SA (1) | SA01220414B1 (en) |
SI (1) | SI1325001T1 (en) |
SK (1) | SK287138B6 (en) |
TR (1) | TR200400376T4 (en) |
TW (1) | TWI306098B (en) |
UA (1) | UA73804C2 (en) |
UY (1) | UY26958A1 (en) |
WO (1) | WO2002032899A1 (en) |
ZA (1) | ZA200302914B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7491719B2 (en) | 2004-05-14 | 2009-02-17 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof, and use thereof as medicaments |
US7579358B2 (en) | 2003-09-26 | 2009-08-25 | Boehringer Ingelheim International Gmbh | Aerosol formulation for inhalation comprising an anticholinergic |
US7727984B2 (en) | 2002-11-15 | 2010-06-01 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
US8420809B2 (en) | 2005-08-15 | 2013-04-16 | Boehringer Ingelheim International Gmbh | Process for the manufacturing of betamimetics |
Families Citing this family (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10200943A1 (en) * | 2002-01-12 | 2003-07-24 | Boehringer Ingelheim Pharma | Process for the preparation of scopine esters |
DE10203753A1 (en) * | 2002-01-31 | 2003-08-14 | Boehringer Ingelheim Pharma | New xanthene carboxylic acid esters, processes for their preparation and their use as medicines |
US7405224B2 (en) | 2002-01-31 | 2008-07-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions |
US7084153B2 (en) | 2002-04-12 | 2006-08-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising steroids and a novel anticholinergic |
DE10216429A1 (en) * | 2002-04-12 | 2003-10-23 | Boehringer Ingelheim Pharma | Synergistic medicaments for treating inflammatory or obstructive respiratory tract diseases, containing quaternized scopine ester anticholinergic agent and steroid, e.g. budesonide |
RS50735B (en) * | 2002-04-12 | 2010-08-31 | Boehringer Ingelheim Pharma Gmbh. & Co.Kg. | Medicaments containing betamimetic drugs and a novel anticholinesterase drug |
US7417051B2 (en) | 2002-04-12 | 2008-08-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising betamimetics and a novel anticholinergic |
DE10256317A1 (en) * | 2002-04-12 | 2003-10-23 | Boehringer Ingelheim Pharma | Synergistic medicaments used for treating inflammaSynergistic medicaments used for treating inflammatory or obstructive respiratory tract diseases, cotory or obstructive respiratory tract diseases, contain quaternized scopine ester anticholinergic agntain quaternized scopine ester anticholinergic agent and beta-mimetic agent e.g. salmeterol salt ent and beta-mimetic agent e.g. salmeterol salt |
DE10224091A1 (en) * | 2002-05-31 | 2003-12-11 | Boehringer Ingelheim Pharma | Technical process for the production of tropenol |
DE60310730T2 (en) | 2002-07-09 | 2007-05-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | PHARMACEUTICAL COMPOSITIONS OF ANTICHOLINERGICA AND P38 KINASE INHIBITORS FOR THE TREATMENT OF RESPIRATORY DISEASES |
DE10230769A1 (en) * | 2002-07-09 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New drug compositions based on new anticholinergics and PDE-IV inhibitors |
DE10230751A1 (en) * | 2002-07-09 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New drug compositions based on new anticholinergics and EGFR kinase inhibitors |
DE10230750A1 (en) * | 2002-07-09 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New drug compositions based on new anticholonergics and NK1 receptor antagonists |
EA009936B1 (en) * | 2002-08-14 | 2008-04-28 | Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг | Aerosol formulation for inhalation containing an anticholinergic agent |
US7244742B2 (en) | 2002-08-17 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic |
DE10237739A1 (en) * | 2002-08-17 | 2004-02-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalable medicament for treating inflammatory or obstructive respiratory diseases, containing synergistic combination of tropane derivative anticholinergic agent, corticosteroid and beta-mimetic agent |
DE10317461A1 (en) | 2003-04-16 | 2004-10-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Preparing microparticles labeled with technetium, useful as powders for inhalation, e.g. to study deposition of pharmaceuticals, such as anticholinergic agents, involves incubation with solution of technetium salt |
US7332175B2 (en) | 2003-05-27 | 2008-02-19 | Boehringer Ingelheim International Gmbh | Long-acting drug combinations for the treatment of respiratory complaints |
DE10323966A1 (en) * | 2003-05-27 | 2004-12-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New long-acting drug combinations for the treatment of respiratory diseases |
US7462367B2 (en) | 2003-07-11 | 2008-12-09 | Boehringer Ingelheim International Gmbh | Anticholinergic powder formulations for inhalation |
US7273603B2 (en) * | 2003-07-11 | 2007-09-25 | Boehringer Ingelheim International Gmbh | HFC solution formulations containing an anticholinergic |
DE10331350A1 (en) * | 2003-07-11 | 2005-01-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalation powder useful for treating respiratory diseases comprises a 9,9-dimethyl-7-(2,2-diphenylpropionyloxy)-3-oxa-9-azatricyclononane salt and a finely divided excipient |
DE602004021815D1 (en) * | 2003-07-28 | 2009-08-13 | Boehringer Ingelheim Pharma | MEDICAMENTS FOR INHALATION WITH STEROIDS AND A NEW FLUORESCARBOXIC ACID ESTER |
JP2007500148A (en) * | 2003-07-28 | 2007-01-11 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Medicament containing PDEIV inhibitor and novel anticholinergic agent and use of the medicament for treating respiratory diseases |
EP1651221B1 (en) * | 2003-07-28 | 2009-01-14 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising betamimetics and an anticholinergic agent |
WO2005013994A1 (en) * | 2003-07-31 | 2005-02-17 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising anticholinergics and a betamimetic |
EP1504756A1 (en) * | 2003-08-06 | 2005-02-09 | Kyowa Hakko Kogyo Co., Ltd | Medicament compositions comprising a heterocyclic compound and an anticholinergic |
CA2547394A1 (en) * | 2004-01-09 | 2005-07-28 | Boehringer Ingelheim International Gmbh | New pharmaceutical compositions based on a scopineester and nicotinamide derivatives |
US7507745B2 (en) | 2004-02-20 | 2009-03-24 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins |
JP2007523116A (en) * | 2004-02-20 | 2007-08-16 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | NOVEL PHARMACEUTICAL COMPOSITION BASED ON ANTICHOLINIC AGONIST AND PEGSUNERCEPT |
US20050186175A1 (en) * | 2004-02-20 | 2005-08-25 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions based on benzilic acid esters and soluble TNF receptor fusion proteins |
DE102004016179A1 (en) * | 2004-03-30 | 2005-10-20 | Boehringer Ingelheim Pharma | Compounds for the treatment of proliferative processes |
ATE427108T1 (en) * | 2004-08-11 | 2009-04-15 | Boehringer Ingelheim Pharma | MEDICINAL PRODUCTS CONTAINING ANTICHOLINERGICS FOR THE TREATMENT OF DISEASES OF THE URINARY TRACT |
DE102004056578A1 (en) * | 2004-11-23 | 2006-05-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhaled drugs containing a new anticholinergic, formoterol and a steroid |
WO2006087316A1 (en) * | 2005-02-16 | 2006-08-24 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions comprising anticholinergics and etiprednol |
WO2006094924A2 (en) * | 2005-03-09 | 2006-09-14 | Boehringer Ingelheim International Gmbh | New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors |
CA2609429A1 (en) * | 2005-05-31 | 2006-12-07 | Boehringer Ingelheim International Gmbh | Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor |
JP2008543806A (en) * | 2005-06-17 | 2008-12-04 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | MRPIV inhibitors for the treatment of respiratory diseases |
DE102005030733A1 (en) | 2005-07-01 | 2007-01-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New drug combinations for the treatment of respiratory diseases containing long-acting beta-2 agonists and at least one other active ingredient |
US20090221664A1 (en) | 2005-10-19 | 2009-09-03 | Abhijit Ray | Pharmaceutical compositions of muscarinic receptor antagonists |
DE102005055961A1 (en) * | 2005-11-24 | 2007-05-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical composition containing specific concentration of quaternary ammonium anticholinergic agent, useful for treatment, by inhalation, of respiratory tract diseases |
DE102005055957A1 (en) * | 2005-11-24 | 2007-07-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosol formulation for inhalation containing an anticholinergic |
DE102005055963A1 (en) * | 2005-11-24 | 2007-07-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosol formulation for inhalation containing an anticholinergic |
JP2010500318A (en) | 2006-08-07 | 2010-01-07 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Pharmaceutical composition for the treatment of respiratory diseases |
EP1958947A1 (en) | 2007-02-15 | 2008-08-20 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type 4 |
EP2124944B1 (en) | 2007-03-14 | 2012-02-15 | Ranbaxy Laboratories Limited | Pyrazolo[3,4-b]pyridine derivatives as phosphodiesterase inhibitors |
ES2569359T3 (en) | 2007-07-06 | 2016-05-10 | Vectura Delivery Devices Limited | Inhaler |
US20100234411A1 (en) * | 2007-07-18 | 2010-09-16 | Boehringer Ingelheim Intermational Gmbh | New Combination for the Treatment of Respiratory Diseases |
EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
EP2082772A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
EP2082767A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
EP2082766A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Blister Strip Coil Forming |
EP2082771A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
EP2082768A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
EP2111861A1 (en) | 2008-04-21 | 2009-10-28 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type IV inhibitors |
EP2662472B1 (en) | 2009-03-31 | 2019-02-27 | Boehringer Ingelheim International Gmbh | Method for coating a surface of a component |
US9265910B2 (en) | 2009-05-18 | 2016-02-23 | Boehringer Ingelheim International Gmbh | Adapter, inhalation device, and nebulizer |
GB0918450D0 (en) | 2009-10-21 | 2009-12-09 | Innovata Ltd | Composition |
WO2011064163A1 (en) | 2009-11-25 | 2011-06-03 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2011064164A1 (en) | 2009-11-25 | 2011-06-03 | Boehringer Ingelheim International Gmbh | Nebulizer |
US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
EP2585151B1 (en) | 2010-06-24 | 2018-04-04 | Boehringer Ingelheim International GmbH | Nebulizer |
WO2012130757A1 (en) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Medical device comprising a container |
US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2013152894A1 (en) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Atomiser with coding means |
US10925964B2 (en) | 2012-12-21 | 2021-02-23 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutical formulation comprising ciclesonide |
US9918995B2 (en) | 2012-12-21 | 2018-03-20 | Boehringer Ingelheim Vetmedica Gmbh | Ciclesonide for the treatment of airway disease in horses |
JP6643231B2 (en) | 2013-08-09 | 2020-02-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Nebulizer |
EP2835146B1 (en) | 2013-08-09 | 2020-09-30 | Boehringer Ingelheim International GmbH | Nebulizer |
ES2874029T3 (en) | 2014-05-07 | 2021-11-04 | Boehringer Ingelheim Int | Nebulizer |
PE20161564A1 (en) | 2014-05-07 | 2017-01-25 | Boehringer Ingelheim Int | NEBULIZER, INDICATOR DEVICE AND CONTAINER |
CA2948071C (en) | 2014-05-07 | 2022-08-30 | Boehringer Ingelheim International Gmbh | Container, nebulizer and use |
HUE051527T2 (en) * | 2014-06-18 | 2021-03-01 | Boehringer Ingelheim Vetmedica Gmbh | Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses |
MA45011A (en) * | 2015-09-04 | 2021-06-02 | Janssen Pharmaceutica Nv | THERAPEUTIC COMPOUND AGAINST PAIN AND ITS SYNTHESIS |
CN113292574B (en) * | 2020-02-21 | 2022-05-03 | 四川大学 | Chiral polycyclic tropane compounds, preparation method and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4003270A1 (en) * | 1990-02-03 | 1991-08-08 | Boehringer Ingelheim Kg | NEW SPEED GASES AND THEIR USE IN MEDICINE PREPARATIONS |
DE4108393A1 (en) * | 1991-03-15 | 1992-09-17 | Boehringer Ingelheim Kg | NEW ESTERS BI-AND TRICYCLIC AMINO ALCOHOLS, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS |
-
2000
- 2000-10-14 DE DE10050994A patent/DE10050994A1/en not_active Withdrawn
-
2001
- 2001-09-28 BR BR0114635-1A patent/BR0114635A/en not_active Expired - Fee Related
- 2001-09-28 PT PT01982374T patent/PT1325001E/en unknown
- 2001-09-28 SI SI200130085T patent/SI1325001T1/en unknown
- 2001-09-28 DE DE50101524T patent/DE50101524D1/en not_active Expired - Lifetime
- 2001-09-28 AT AT01982374T patent/ATE259805T1/en active
- 2001-09-28 TR TR2004/00376T patent/TR200400376T4/en unknown
- 2001-09-28 HU HU0301203A patent/HUP0301203A3/en unknown
- 2001-09-28 JP JP2002536281A patent/JP4109106B2/en not_active Expired - Lifetime
- 2001-09-28 SK SK435-2003A patent/SK287138B6/en not_active IP Right Cessation
- 2001-09-28 CN CNB018171443A patent/CN1275962C/en not_active Expired - Lifetime
- 2001-09-28 IL IL15533401A patent/IL155334A0/en active IP Right Grant
- 2001-09-28 WO PCT/EP2001/011226 patent/WO2002032899A1/en active IP Right Grant
- 2001-09-28 NZ NZ525836A patent/NZ525836A/en not_active IP Right Cessation
- 2001-09-28 ME MEP-399/08A patent/MEP39908A/en unknown
- 2001-09-28 EA EA200300459A patent/EA005816B1/en not_active IP Right Cessation
- 2001-09-28 UA UA2003054186A patent/UA73804C2/en unknown
- 2001-09-28 PL PL360673A patent/PL207311B1/en not_active IP Right Cessation
- 2001-09-28 KR KR1020037005256A patent/KR100830359B1/en not_active IP Right Cessation
- 2001-09-28 DK DK01982374T patent/DK1325001T3/en active
- 2001-09-28 CA CA002425557A patent/CA2425557C/en not_active Expired - Lifetime
- 2001-09-28 EE EEP200300151A patent/EE05179B1/en not_active IP Right Cessation
- 2001-09-28 MX MXPA03003160A patent/MXPA03003160A/en active IP Right Grant
- 2001-09-28 RS YUP-295/03A patent/RS50464B/en unknown
- 2001-09-28 AU AU2002213975A patent/AU2002213975B2/en not_active Expired
- 2001-09-28 EP EP01982374A patent/EP1325001B1/en not_active Expired - Lifetime
- 2001-09-28 ES ES01982374T patent/ES2215147T3/en not_active Expired - Lifetime
- 2001-09-28 EP EP03023933A patent/EP1382606A3/en not_active Withdrawn
- 2001-09-28 AU AU1397502A patent/AU1397502A/en active Pending
- 2001-10-02 SA SA01220414A patent/SA01220414B1/en unknown
- 2001-10-10 UY UY26958A patent/UY26958A1/en not_active Application Discontinuation
- 2001-10-12 PE PE2001001018A patent/PE20020433A1/en not_active Application Discontinuation
- 2001-10-12 MY MYPI20014765A patent/MY127144A/en unknown
- 2001-10-12 AR ARP010104785A patent/AR035589A1/en active Pending
- 2001-10-12 TW TW090125220A patent/TWI306098B/en not_active IP Right Cessation
-
2003
- 2003-03-28 BG BG107688A patent/BG66225B1/en active Active
- 2003-04-07 EC EC2003004542A patent/ECSP034542A/en unknown
- 2003-04-10 IL IL155334A patent/IL155334A/en not_active IP Right Cessation
- 2003-04-11 NO NO20031693A patent/NO328207B1/en not_active IP Right Cessation
- 2003-04-11 HR HR20030278A patent/HRP20030278B1/en not_active IP Right Cessation
- 2003-04-11 ZA ZA200302914A patent/ZA200302914B/en unknown
-
2004
- 2004-05-20 HK HK04103582A patent/HK1060566A1/en not_active IP Right Cessation
-
2008
- 2008-02-14 JP JP2008033492A patent/JP2008120834A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7727984B2 (en) | 2002-11-15 | 2010-06-01 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
US7786111B2 (en) | 2002-11-15 | 2010-08-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
US8044046B2 (en) | 2002-11-15 | 2011-10-25 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
US7579358B2 (en) | 2003-09-26 | 2009-08-25 | Boehringer Ingelheim International Gmbh | Aerosol formulation for inhalation comprising an anticholinergic |
US7491719B2 (en) | 2004-05-14 | 2009-02-17 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof, and use thereof as medicaments |
US8034809B2 (en) | 2004-05-14 | 2011-10-11 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
US8420809B2 (en) | 2005-08-15 | 2013-04-16 | Boehringer Ingelheim International Gmbh | Process for the manufacturing of betamimetics |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2425557A1 (en) | Anticholinergic agents that can be used as medicaments and method for the production thereof | |
CA2425560A1 (en) | Anticholinergics, processes for preparing them and their use as pharmaceutical compositions | |
SE0102438D0 (en) | New compounds | |
CA2290918A1 (en) | Heteroaromatic bicyclic derivatives useful as anticancer agents | |
MY136034A (en) | New medicaments for the treatment of chronic obstructive pulmonary disease | |
AU2002319814A1 (en) | Substituted 1h-dihydropyrazoles, their preparation and use | |
CA2414095A1 (en) | Novel compounds | |
MY129613A (en) | Cannabinoid receptor binding compounds | |
WO2004060882A8 (en) | Cb 1/cb 2 receptor ligands and their use in the treatment of pain | |
UY27629A1 (en) | NEW ANTI-POLYNERGICS, PROCEDURE FOR PREPARATION, AS WELL AS ITS USE AS MEDICATIONS | |
RS65604A (en) | Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals | |
HK1093351A1 (en) | Disperse azo dyestuffs | |
DE602004011966D1 (en) | Heterocyclylverbindungen | |
DE69504509T2 (en) | THIAZOLIDE DERIVATIVES, THEIR PRODUCTION AND THE MEDICINES THAT CONTAIN | |
EP1598341A8 (en) | DPP-IV inhibitors | |
CA2112084A1 (en) | Antidepressant and antiparkinsonian compounds | |
IT1300055B1 (en) | HETEROCYCLES WITH DIPHENYL-SUBSTITUTED 5-TERM RING THEIR PREPARATION PROCEDURE AND THEIR USE AS DRUGS | |
WO2003016316A8 (en) | Diazacycloalkanes as oxytocin agonists | |
WO2003015780A8 (en) | Isoxazolopyridinones and use thereof in the treatment of parkinson's disease | |
MY120550A (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions. | |
CA2219311A1 (en) | 10,13,15-trioxatricyclo[9.2.1.1.9.6]-pentadecanone derivatives, method for their production and pharmaceutical compositions containing them | |
RS20050384A (en) | Carbamic acid esters with an anticholinergic action | |
CA2399377A1 (en) | New positive allosteric ampa receptor modulators (paarm), processes for preparing them and their use as pharmaceutical compositions | |
CA2434187A1 (en) | Androgenic 7-substituted 11-halogenated steroids | |
HUP0302408A2 (en) | Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20210928 |